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Abstract
Despite the recent developments that have been made in the field of percutaneous left main (LM) intervention, the
treatment of distal LM bifurcation remains challenging. The provisional one-stent approach for LM bifurcation has
shown more favorable outcomes than the two-stent technique, making the former the preferred strategy in most
types of LM bifurcation stenosis. However, elective two-stent techniques, none of which has been proven superior
to the others, are still used in patients with severely diseased large side branches to avoid acute hemodynamic
compromise. Selecting the proper bifurcation treatment strategy using meticulous intravascular ultrasound evaluation
for side branch ostium is crucial for reducing the risk of side branch occlusion and for improving patient outcomes. In
addition, unnecessary complex intervention can be avoided by measuring fractional flow reserve in angiographically
isolated side branches. Most importantly, good long-term clinical outcomes are more related to the successful
procedure itself than to the type of stenting technique, emphasizing the greater importance of optimizing
the chosen technique than the choice of method.
Keywords: Left main coronary artery, Percutaneous coronary intervention, Bifurcation, Intravascular ultrasound,
Fractional flow reserve
Background
Results of randomized trials and observational studies
found that percutaneous coronary intervention (PCI) is
a potential alternative to bypass surgery for patients with
unprotected left main (LM) coronary artery stenosis [1].
However, PCI for LM bifurcation is technically demand-
ing and has been associated with high rates of adverse
clinical events [2]. In addition, a lack of randomized
clinical trials focusing on distal LM intervention has
often led to uncertainties regarding the optimal stenting
strategy. In general, based on non-randomized studies and
extrapolations from the results of non-LM bifurcation
trials, the provisional one-stent approach has been consid-
ered as a preferred strategy over the elective two-stent
technique for patients with LM bifurcation disease. In
practice, however, two-stent techniques are chosen more
frequently for LM bifurcation than for non-LM lesions
due to concerns regarding the ischemic myocardial vol-
ume, which would be jeopardized by adverse events [3].
This review therefore discusses the optimal methods of
distal LM bifurcation stenting from a practical point of
view.
Outcomes of provisional one-stent and two-stent
technique
The provisional approach is a single-stent strategy that
allows the positioning of a second stent, if required
(Fig. 1). Similar to non-LM bifurcations, several studies
reported that, compared with two-stent techniques, the
provisional one-stent approach for distal LM bifurcation
was associated with more favorable outcomes, including
lower risks of major adverse cardiac events [4–6], death
[6], myocardial infarction [5, 6], and target vessel revas-
cularization [5–7] (Table 1). In addition, the provisional
one-stent approach was found to reduce the risk of stent
thrombosis [6, 7]. Based on these results, the provisional
one-stent approach has been preferred in the treatment
of LM bifurcation stenosis [8], with more than 60 % of
patients with LM bifurcation in real-world practice
treated using the provisional one-stent technique [5].
However, all previous studies were observational, suggest-
ing the need for randomized controlled studies to properly
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evaluate the superiority of the provisional approach over
double stenting in patients with LM bifurcation disease.
Selecting a left main bifurcation treatment strategy
Because of the large myocardial volume supplied by the
left circumflex artery (LCX) in many patients, the possibil-
ity of circulatory collapse after main vessel (MV) stenting
should always be considered. Therefore, the presence or
absence of significant disease in the ostium of the LCX is
regarded as an important factor in choosing a stenting
strategy. The provisional one-stent approach is preferred
for LM bifurcations with insignificant stenosis at the ostial
LCX or a non-dominant left coronary system (Fig. 2). By
contrast, the elective two-stent technique is preferred in
patients with significant ostial stenosis of the LCX with a
dominant left coronary arterial system [9, 10]. Fractional
flow reserve (FFR) evaluation for the side branch (SB) has
provided valuable information on the relation between
physiological and angiographic severity and can be useful
to make correct choice of the treatment strategy [11].
Fig. 1 Provisional approach for distal left main stenosis. Coronary angiography showed a “true” LM bifurcation lesion (Medina 1.1.1) (a) while
intravascular ultrasound revealed very minimal disease at the ostium of the left circumflex artery (b). Provisional single stenting was performed (c), with
the final angiogram showing an acceptable result without side branch compromise (d)
Table 1 Outcomes of provisional single stenting versus double stenting
Reference Year Numbers of patients FU
(M)





MACE Death or MI Death MI TVR



























Abbreviations: FU follow-up, M months, MACE major adverse cardiac events, MI myocardial infarction, TVR target vessel revascularization
aHazard ratios are for patients undergoing the provisional approach, compared with patients undergoing double stenting
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Table 2 summarizes the selection criteria for stenting
strategies based on the anatomic features involving the
LM bifurcation.
In general, LM bifurcation disease is mostly diffuse,
not focal [12], and angiography is inaccurate in assessing
the disease severity of both branch ostia [13]. Thus
angiography-guided intervention may lead to SB occlu-
sion for a “true” bifurcation or unnecessary complex
intervention that may be preventable. As intravascular
ultrasound (IVUS) provides more accurate informa-
tion on the disease status of the distal LM complex,
including the LCX ostium, pre-procedural IVUS evalu-
ation is very helpful in selecting an appropriate and safe
stenting strategy. Previous studies reported that the use
of IVUS reduced the risk of SB occlusion after MV
stenting in coronary bifurcation lesions [9]. Moreover,
IVUS-guided PCI for LM disease has been associated
with low mortality rates [14, 15]. In association with
the functional concept, IVUS-derived minimal lumen
>3.7 mm2 or plaque burden <56 % in the LCX ostium
can exclude functional SB compromise (FFR <0.80) after
MV stenting in treating LM bifurcations [16]. However, in
Fig. 2 Fractional flow measurement after main vessel stenting. A patient with a distal LM bifurcation disease (a) underwent provisional one-stent
implantation (b). After main vessel stenting, significant stenosis was observed at the ostium of the left circumflex artery (c). However, fractional
flow reserve value was 0.92, indicating functionally insignificant stenosis (d), and suggesting that additional procedures were unnecessary
Table 2 Selection criteria for the provisional one-stent approach versus the planned two-stent technique
Strategy Anatomical features
Favors the Provisional Approach • Insignificant stenosis at the ostial LCX with MEDINA classification 1,1,0 or 1,0,0
• Small LCX <2.5 mm in diameter
• Diminutive LCX, right dominant coronary system
• Wide angle between LAD and LCX
• No concomitant disease or only focal disease in LCX
Favors the Two-Stent Technique • Significant stenosis at the ostial LCX with MEDINA classification 1,1,1 or 1,0,1 or 0,1,1
• Large LCX ≥2.5 mm in diameter
• Diseased left dominant coronary system
• Narrow angle between LAD and LCX
• Concomitant diffuse disease in LCX
Abbreviations: LAD left anterior descending artery, LCX left circumflex artery
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addition to these absolute numerical values reflecting
lumen patency, relative plaque distribution [17] and the
presence of calcified plaque [18] should also be considered
in order to avoid the SB compromise after MV stenting.
Determining SB intervention using the provisional
one-stent approach
Patients who develop ischemic symptoms or signs after
MV stenting attributable to SB compromise definitely
require further SB intervention. However, it remains
unclear whether further treating asymptomatic angio-
graphic stenosis of an SB ostium after MV stenting
provides clinical advantages. Nevertheless, in practice,
additional SB interventions are frequently performed,
primarily because of concerns regarding the future
likelihood of SB deterioration.
Two small pilot studies suggested the benefit of FFR-
guided decision making for SB intervention after MV
stenting in LM bifurcation [16, 19]. These studies re-
ported a considerable discrepancy between angiographic
stenosis and FFR values, in that less than one-third of
angiographically isolated LCX ostia were functionally
significant (FFR, <0.80). This finding, and results suggest-
ing that a FFR >0.80 is a strong predictor of favorable sur-
vival and low event rates in patients with coronary artery
disease, including intermediate LM disease [20, 21], indi-
cates that incorporating the FFR-guided PCI strategy to
treat the isolated LCX may reduce the incidence of
additional SB intervention and associated procedure-
related complications. However, long-term clinical trials
are needed to validate this FFR-guided SB approach in
LM bifurcation stenting.
Elective two-stent techniques
A planned two-stent approach can be attempted if the
operator is concerned about acute complications, in-
cluding hemodynamic compromise and peri-procedural
myocardial infarction following SB loss. Current two-stent
techniques commonly used for distal LM bifurcations
include crush and its variants, culotte, and simultaneous
kissing stent technique. Because few studies have evalu-
ated the comparative outcomes of these two-stent tech-
niques, there are still no clear guidelines in selecting a
particular technique relative to the specific anatomy of
the LM bifurcation lesion. Thus, selecting a proper
stenting technique should depend on each the patient’s
clinical manifestations, LM bifurcation morphology
(e.g. the diameter of the two branches, bifurcation
angle, severity of the ostial SB stenosis, extent of the
MV disease), and the operator’s preference. Also, the
operator should make every effort to understand the
advantages and disadvantages of the various two-stent
techniques.
The crush technique is a modified version of the T or
kissing stent technique, in which the main branch (MB)
stent crushes the SB stent against the MB wall. The clas-
sic crush technique is performed by retracting the SB
stent 4–5 mm into the MB lumen, followed by crushing
by the MB stent. In contrast with the shortcomings of
T-stenting, which may leave a small un-stented gap at
the SB ostium, the crush technique provides complete
lesion coverage for the SB ostium and can be applied to
any anatomic variation of true LM bifurcation. By con-
trast, the formation of three layers of struts covering the
SB ostium just after MB stenting can make the final
kissing balloon inflation (FKI) laborious and may cause
unsatisfactory results. Because of these limitations and
the complex procedures involved, the mini-crush tech-
nique was developed as a variant of the classic crush
method. The mini-crush technique involves minimal
(usually 1–2 mm) retraction of the SB stent into the MB
before crushing, thus avoiding a large area with three
strut layers and minimizing residual metallic stenosis at
the SB ostium [22]. The double-kissing crush technique,
another variant of the classic crush method, includes
additional kissing balloon inflation between SB crushing
and MV stenting and can further enhance stent appos-
ition and facilitate FKI [23]. The culotte technique con-
sists of the sequential implantation of two stents into
both branches, with the MV stent implanted through the
SB stent and protruding into the MB lumen. Conse-
quently, the proximal MV is covered by two overlapping
stents. This technique is suitable for all angles of bifur-
cations and provides near-perfect coverage of the SB
ostium. However, it may cause intra-procedural acute
closure of the MB after SB stenting, which can be cata-
strophic during interventions for distal LM disease.
Since the proximal double stent layers can lead to
delayed endothelialization and subsequent stent throm-
bosis, the stents should be overlapped minimally in the
proximal MV segment whenever possible. Finally, the
distal MB stent at the ostial left anterior descending
artery can be under-expanded because of the positioning
through the SB stent strut. The simultaneous kissing stent
technique consists of the delivery and implantation of two
stents, together with a two-barrel metallic carina, in the
LM. The main advantage of this technique is that it guar-
antees the patency of both branches during the procedure
and does not require rewiring for FKI. This technique is
preferable in narrow-angle bifurcations, where the LM
diameter is much larger than the diameters of the LAD
and LCX. Unfortunately, this technique is now rarely used
because of several concerns, including difficulty placing
the stent proximal to the double barrel, the formation
of a new diaphragmatic metal membrane, and difficulty
in wiring in case of restenosis [24]. Nevertheless, its
technical ease and rapidity make it an appropriate
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option for patients in highly unstable presentations,
such as ST-elevation myocardial infarction involving
the LM bifurcation. Importantly, one should always
beware of the increased risk of bleeding since certain
two stent techniques require 7–8Fr guiding catheter
with femoral artery approach.
The particular characteristics of the LM bifurcation
should be considered during intervention, in that the
absolute difference between the reference vessel diam-
eter of proximal MV and distal MB diameter is relatively
large. In this regard, the proximal optimization tech-
nique may be of particular importance in LM bifurcation
intervention [25]. This technique promotes adequate
stent apposition in the LM stem, helps to avoid ablum-
inal rewiring by a second wire, and facilitates rewiring
the SB through a distal stent cell which is important for
complete scaffolding of the SB ostium. Basically, the
choice of stent diameter should be based on the distal MV
reference diameter to minimize carina shifting [26, 27].
However, it is also important to select a stent where the
platform in that particular nominal diameter accommo-
dates expansion to the reference diameter of the LM
coronary artery. The final decision should be made to
balance these considerations.
Recently, several dedicated stents for bifurcations have
been recently adopted for the treatment of LM disease
[28]. These devices offer common advantages over con-
ventional drug-eluting stents (DES) to cover the LM
bifurcation segment. The design of these dedicated bi-
furcation stents and balloons conforms to the natural
anatomy of the bifurcation and can facilitate a more
effective scaffolding of the SB ostium. Furthermore,
these devices provide easier access to the main and
side branch which lowers the risk of SB loss during
the procedure. Several studies have shown that stent-
ing of LM with these new-dedicated stents is safe and
effective both at short and mid-term follow-up [29–32].
Although, conceptually, the advantages offered by these
devices may improve clinical outcomes after PCI of LM
bifurcations, the success of currently available systems
depends on specific anatomic features of bifurcations, and
further studies are needed to define their role on LM
bifurcations.
Systematic kissing balloon inflation in provisional 1-stent
approach
Systematic FKI after MV stenting is frequently performed
in patients undergoing the provisional one-stent approach.
Although FKI theoretically allows better strut contact to-
gether with the SB opening and is regarded as mandatory
in performing any two-stent technique, its role in one-
stent techniques remains unclear. A recent analysis in-
volving 413 patients who underwent provisional single
stenting at Asan Medical Center may provide insight into
the use of FKI [33]. Of the 413 patients, 96 received FKI
after MV stenting, whereas 318 did not. During a 2 year
follow-up period, the rate of the composite of death,
myocardial infarction, or target lesion revascularization
did not differ significantly between these groups regardless
of angiographic SB stenosis (12.5 % vs. 8.5 %; adjusted
hazard ratio [HR], 1.10; 95 % confidence interval [CI],
0.49–2.49, p = 0.82). Moreover, although statistically in-
significant, there was a trend toward more frequent
target vessel revascularization in the FKI group (8.1 %
vs. 4.8 %; adjusted HR, 1.12; 95 % CI, 0.40–3.11, p = 0.83).
Another small observational study showed similar results
[34]. Therefore, systematic FKI after MV stenting in the
provisional one-stent strategy may not provide better
long-term clinical outcomes and may be unnecessary.
Importance of intravascular imaging-guided optimization
Stent under-expansion is the most important cause of
DES failure. A minimal stent area (MSA) less than
5.0–5.5 mm2 was the best predictor on IVUS of first-
generation DES restenosis or early thrombosis [35, 36].
However, there are no data suggesting the optimal MSA
cutoff to predict restenosis and long-term clinical out-
comes after DES treatment of LM stenosis—especially
since in-stent restenosis can occur within any of the 4
segments: the LCX ostium, the LAD ostium, the polygon
of confluence (POC), and the LM above the POC.
The optimal IVUS-MSA criteria for preventing in-stent
restenosis were assessed in 403 patients undergoing DES
implantation for LM coronary artery disease [37]. The
best IVUS-MSA criteria that predicted angiographic re-
stenosis on a segmental basis were 5.0 mm2 for the LCX
ostium, 6.3 mm2 for the LAD ostium, 7.2 mm2 for the
POC, and 8.2 mm2 for the proximal LM above the POC.
Using these criteria, 133 (33.8 %) of the 403 patients
had under-expansion of at least one of the pre-specified
segments. In addition, under-expansion was more sig-
nificantly frequent in the two-stent than in the single-
stent group (54 % vs. 27 %, p = 0.001). In the two-stent
group, the LCX ostium was the most common site of
under-expansion (37 %), which may explain the greater
risk of restenosis when distal LM bifurcation lesions
are treated with a two-stent strategy. Overall, angio-
graphic in-stent restenosis was significantly more frequent
in lesions with than without under-expansion (24.1 % vs.
5.4 %, p = 0.001). Even in the two-stent group, the lesions
with complete expansion at all sites showed a restenosis
rate of only 6 %, similar to that in the single-stent group
(6.3 %) or in patients with non-bifurcated LM coronary
arteries (4.5 %). Furthermore, a smaller IVUS-MSA pre-
dicted angiographic in-stent restenosis 9 months after
DES implantation to treat LM disease, and post-stenting
under-expansion was an independent predictor of
2 year major adverse cardiac events, especially repeat
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revascularization. This study demonstrates that whichever
2-stent technique is chosen for the LM bifurcation dis-
ease, achieving sufficient post-stenting cross-sectional area
is important for the favorable clinical outcomes.
Although the clinical impact of IVUS-guided stenting
for unprotected LM coronary artery is unclear, as are
several cost-benefit issues [38], this adjuvant method has
been supported by several recent studies. For example, a
subgroup analysis from the MAIN-COMPARE registry,
including 201 propensity-score matched pairs, showed
that 3 year mortality rates tended to be lower with IVUS
than with angiography guidance (6.3 % vs. 13.6 %, log-
rank p = 0.063; HR, 0.54; 95 % CI, 0.28–1.03) [14]. In
particular, the 3 year mortality rates for the 145 matched
pairs of patients undergoing DES implantation was
significantly lower with IVUS than with angiography
guidance (4.7 % vs. 16.0 %, log-rank p = 0.048; HR,
0.39; 95 % CI, 0.15–1.02). Interestingly, mortality rates
started to diverge more than 1 year after the procedure.
Since IVUS guidance did not reduce the risk of mortality
in 47 matched pairs of patients undergoing bare metal
stent implantation (8.6 % vs. 10.8 %, log-rank p = 0.35;
HR, 0.59), this study indicated that IVUS guidance
may play a role in reducing very late stent thrombosis
and subsequent long-term mortality. A recent IVUS-
TRONCO-ICP Spanish study also demonstrated the
importance of IVUS surveillance during LM coronary
artery stenting, with the incidence of the composite
of cardiac death, myocardial infarction, and target lesion
revascularization, as well as stent thrombosis at 3 years,
being lower in the IVUS-guided group [15].
Frequency domain optical coherence tomography (OCT)
is another attractive intravascular imaging tool for stent
optimization. OCT offers superior resolution and can
identify stent failure such as stent malopposition, edge
dissections, tissue protrusion, and thrombus more clearly
than IVUS [39]. Several pilot studies indeed showed that
OCT-guided optimization of LM disease were feasible and
safe [40, 41]. However, since blood must be adequately
replaced by iodine contrast through a well-engaged guid-
ing catheter for a clear image by OCT, evaluation of the
LM ostium or a relatively large LM is often problematic.
Furthermore, there is no standardized OCT criterion for
optimizing stent implantation, particularly for the LM
bifurcation, which hinders the use of this novel imaging
modality to guide LM intervention. Nevertheless, with
accumulating clinical data and experience, it is expected
that OCT will be a useful adjunctive tool for the treatment
of LM disease in near future.
Conclusions
Figure 3 is a schematic flow chart summarizing clinical
strategies for treating distal LM bifurcation disease. Care-
ful selection of candidates for the provisional approach is
Fig. 3 Flow chart for the interventional treatment of distal left main bifurcation lesions. *In general, minimal lumen area >4 mm2 or
plaque burden <50 % of the ostium of the left circumflex artery is considered insignificant stenosis. †The stent should be well opposed
to the vessel wall and sufficiently expanded to avoid restenosis (minimal stent area: 5 mm2 for the ostium of the left circumflex artery,
6 mm2 for the proximal left anterior descending artery, 7 mm2 for the polygon of confluence, and 8 mm2 for the distal left main artery),
without procedure-related complications. Abbreviations: FKB, final kissing balloon; IVUS, intravascular ultrasound; LAD, left anterior descending artery;
LCX, left circumflex artery; LM, left main; PCI, percutaneous coronary intervention
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the most important step in avoiding procedure-related
complications and ensuring favorable individual outcomes.
Incorporating the FFR-guided PCI strategy in treating
isolated LCX may further help avoid unnecessary SB inter-
ventions. Meticulous evaluation of LM bifurcations using
intravascular imaging is crucial in selecting the proper
stent strategy and in achieving optimal stent results.
Abbreviations
CI: confidence interval; DES: drug-eluting stent; FFR: functional flow reserve;
FKI: final kissing balloon inflation; HR: hazard ratio; IVUS: intravascular
ultrasound; LCX: left circumflex artery; LM: left main; MB: main branch;
MSA: minimal stent area; MV: main vessel; OCT: optical coherence
tomography; PCI: percutaneous coronary intervention; POC: polygon of
confluence; SB: side branch.
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